Sumitomo Pharma (OTCMKTS:DNPUF) Downgraded to “Hold” at Jefferies Financial Group

Jefferies Financial Group cut shares of Sumitomo Pharma (OTCMKTS:DNPUFGet Rating) from a buy rating to a hold rating in a research note published on Monday, The Fly reports.

Sumitomo Pharma Stock Performance

OTCMKTS DNPUF opened at $5.32 on Monday. Sumitomo Pharma has a fifty-two week low of $5.21 and a fifty-two week high of $8.67. The stock’s 50-day moving average is $6.12 and its two-hundred day moving average is $6.74.

About Sumitomo Pharma

(Get Rating)

Sumitomo Pharma Co, Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia.

Recommended Stories

The Fly logo

Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with's FREE daily email newsletter.